He will take up his new position on April 1st, 2014, reporting directly to Christel Bories, Deputy CEO of the Ipsen...
He will take up his new position on April 1st, 2014, reporting directly to Christel Bories, Deputy CEO of the Ipsen...
For six years (2002-8) Zinta was Managing Director of the Turkish arm of Boehringer Ingelheim and for the last 12...
Henk was at Plant Genetic Systems for a decade, first as a researcher and then as a business development manager....
Hoefer has gained more than 20 years of international non-clinical development and management experience in academic...
deBethizy brings more than 20 years of experience in managing and financing life science related technologies, and has...
Kilbee will be responsible for driving the portfolio globally including increased emphasis on digital and content
Dr Dani Bach (formerly of Index Ventures) joins as Managing Partner, Dr Jacques Mizrahi joins in a consulting role as...
Tasker will lead the Company’s clinical development activities as it advances its rich pipeline of novel GPCR-targeted...
Annika has over twenty years’ experience in the healthcare sector, both as a sell-side analyst and investor. She has a...
John’s career spans twenty years, with extensive experience leading and working with international healthcare...
With a career spanning over 15 years in recruitment, training and HR, Carly Brunsden joins the SEC team with a solid...
Having previously worked for global names such as Quintiles and Abbott Laboratories (AbbVie), Barnett has a career...
Prof. Hannah Blau holds the position of Director, Pulmonary institute & Chair of the Graub Cystic Fibrosis Center,...
The move sees Paolo Morelli move into the role of Chairman for CROS NT allowing him to dedicate more time to PMH the...
Evangelista joins from Deloitte Consulting, and brings with him more than two decades of life sciences industry...